12th Annual Cholangiocarcinoma Foundation Conference

April 9-11 2025, Salt Lake City

 

Salt Lake City, Utah

 

The event is a unique opportunity for patients and caregivers to join leading experts in shaping the future of cholangiocarcinoma research. The initiative brings together patients, caregivers, advocates, oncologists, scientists, industry representatives, regulators, and other specialists worldwide to review scientific evidence, share insights, and reach a consensus on the research focus going forward to optimize existing funding and attract new funding.

 

This year’s Conference is an effort between CCF’s International Cholangiocarcinoma Research Network (ICRN) and the European Cooperation in Science and Technology (COST)-Action: Precision-BTC-Network.

 

Deadline for Abstract/Poster submission: January 31, 2025. 

 

Registration is now open! Click the link below to attend

 

 

AMMF 2025 European Cholangiocarcinoma Conference

May 7-9, Stansted

 

Stansted, United Kingdom

 

The theme for this year's conference is: 'Cholangiocarcinoma: A Fairer Deal, Faster – RETHINKING LIVER CANCER'. 

 

The conference will focus on tackling health inequalities in cholangiocarcinoma diagnosis and treatment, building on insights from AMMF’s data project. An international faculty of some 40 speakers will discuss key challenges in earlier diagnosis, multi-disciplinary assessments, and specialist referrals, all of which influence patient outcomes.

 

Click the link below to register & for more information!

 

Action Meeting & Liquid Biopsy Monothematic Conference

May 22-23 2025, Mallorca

 

Hotel Palma Bellver

Mallorca, Spain

 

The Monothematic Conference Liquid Biopsy in BTC: from bench to bedside will be held jointly with the annual meeting of the COST Action Precision-BTC Network (Management Committee and General Meeting). This meeting will focus on biliary tract cancer, with a major aim to consolidate current knowledge and to draw a roadmap towards the adoption of liquid biopsy as a key tool in the diagnosis and personalized treatment of biliary tumors. Additionally, the conference aims to discuss the latest findings related to epidemiology, new therapies, artificial intelligence and preclinical models for the development of new drugs for patients with biliary tumors.

 

Joint meeting ENS-CCA/PRECISION-BTC-NETWORK

July 1-2 2024, Krakow

 

Jagiellonian University, Didactic Centre of the Faculty of Law and Administration

Krakow, Poland

 

The annual meeting of the COST Action PRECISION-BTC-NETWORK (Management Committee and General Meeting) to be held jointly with the bi-annual ENS-CCA conference.

This meeting will focus on biliary tract cancer, covering a wide range of topics including adjuvant treatment, immunotherapy, biomarkers for patients’ selection, the role of artificial intelligence in guiding treatment choice, discussion of the data from the large international European registry on bile duct cancers, development of novel therapeutics with a focus on targeting the microenvironment and the immune system. 

 

Event Photos!